Huifang Li
Jinzhong University(CN)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Estrogen and related hormone effects, Cancer Immunotherapy and Biomarkers, Cancer-related molecular mechanisms research, Mesenchymal stem cell research
Most-Cited Works
- → Targeted Therapy for BRAFV600E Malignant Astrocytoma(2011)150 cited
- → Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor(2014)118 cited
- → Cdk5 Suppresses the Neuronal Cell Cycle by Disrupting the E2F1–DP1 Complex(2010)96 cited
- → Targeting the Binding Function 3 (BF3) Site of the Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole Derivatives(2013)88 cited
- → PD-1-mediated inhibition of T cell activation: Mechanisms and strategies for cancer combination immunotherapy(2024)62 cited
- → Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)(2013)59 cited
- → Association of socioeconomic and lifestyle factors with chronic non-communicable diseases and multimorbidity among the elderly in rural southwest China(2019)58 cited
- → Simultaneous detection of human enterovirus 71 and coxsackievirus A16 in clinical specimens by multiplex real-time PCR with an internal amplification control(2008)55 cited
- → Discovery of 1H-Indole-2-carboxamides as Novel Inhibitors of the Androgen Receptor Binding Function 3 (BF3)(2014)55 cited
- → Gabapentin decreases epileptiform discharges in a chronic model of neocortical trauma(2012)54 cited